These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17823102)

  • 1. Drug interactions with smoking.
    Kroon LA
    Am J Health Syst Pharm; 2007 Sep; 64(18):1917-21. PubMed ID: 17823102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interactions with tobacco smoking. An update.
    Zevin S; Benowitz NL
    Clin Pharmacokinet; 1999 Jun; 36(6):425-38. PubMed ID: 10427467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of variable cigarette consumption on the interaction with clozapine and olanzapine.
    Haslemo T; Eikeseth PH; Tanum L; Molden E; Refsum H
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1049-53. PubMed ID: 17089108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective.
    Desai HD; Seabolt J; Jann MW
    CNS Drugs; 2001; 15(6):469-94. PubMed ID: 11524025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine.
    Zullino DF; Delessert D; Eap CB; Preisig M; Baumann P
    Int Clin Psychopharmacol; 2002 May; 17(3):141-3. PubMed ID: 11981356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Smoking cessation and drug interactions].
    Madsen HKL; Gulløv M; Farver-Vestergaard I; Hjort P; Nielsen LP; Løkke A; Haastrup MB
    Ugeskr Laeger; 2022 Aug; 184(35):. PubMed ID: 36065858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically significant pharmacokinetic interactions between dietary caffeine and medications.
    Carrillo JA; Benitez J
    Clin Pharmacokinet; 2000 Aug; 39(2):127-53. PubMed ID: 10976659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine. Pharmacokinetic and pharmacodynamic profile.
    Callaghan JT; Bergstrom RF; Ptak LR; Beasley CM
    Clin Pharmacokinet; 1999 Sep; 37(3):177-93. PubMed ID: 10511917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of smoking cessation: potentially risky effects on prescribed medications.
    Schaffer SD; Yoon S; Zadezensky I
    J Clin Nurs; 2009 Jun; 18(11):1533-40. PubMed ID: 19490292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2.
    Plowchalk DR; Rowland Yeo K
    Eur J Clin Pharmacol; 2012 Jun; 68(6):951-60. PubMed ID: 22258279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tobacco smoking and drug interactions].
    Molden E; Spigset O
    Tidsskr Nor Laegeforen; 2009 Mar; 129(7):632-3. PubMed ID: 19337332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tobacco smoking cessation on stable clozapine or olanzapine treatment.
    Lowe EJ; Ackman ML
    Ann Pharmacother; 2010 Apr; 44(4):727-32. PubMed ID: 20233914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.
    Faber MS; Fuhr U
    Clin Pharmacol Ther; 2004 Aug; 76(2):178-84. PubMed ID: 15289794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Smoking and drug interactions].
    Rouhos A; Raaska K
    Duodecim; 2012; 128(10):1073-80. PubMed ID: 22724322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating patients with respiratory disease who smoke.
    Braganza G; Chaudhuri R; Thomson NC
    Ther Adv Respir Dis; 2008 Apr; 2(2):95-107. PubMed ID: 19124362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and recognition of highly significant medication-smoking cessation interactions in a smoke-free hospital.
    Chui CY; Taylor SE; Thomas D; George J
    Drug Alcohol Depend; 2019 Jul; 200():78-81. PubMed ID: 31108404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gender and moderate smoking on the pharmacokinetics and effects of the CYP1A2 substrate tizanidine.
    Backman JT; Schröder MT; Neuvonen PJ
    Eur J Clin Pharmacol; 2008 Jan; 64(1):17-24. PubMed ID: 17955229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone toxicity due to smoking cessation--a case report on the drug-drug interaction involving cytochrome P450 isoenzyme 1A2.
    Wahawisan J; Kolluru S; Nguyen T; Molina C; Speake J
    Ann Pharmacother; 2011 Jun; 45(6):e34. PubMed ID: 21666091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta.
    Czekaj P; Wiaderkiewicz A; Florek E; Wiaderkiewicz R
    Arch Toxicol; 2005 Jan; 79(1):13-24. PubMed ID: 15448981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Switching to e-cigarettes affects drug concentration].
    Berm EJ; Ruijsbroek R; Loonen AJ; Goethals KR; Wilffert B; van Hasselt F
    Ned Tijdschr Geneeskd; 2015; 159():A9090. PubMed ID: 26200424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.